Characteristics of hospitalizations among patients receiving immune checkpoint inhibitors at a community teaching hospital.
Brendan RasorRachel HendersonKin ChanPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)
Reasons for admission in the study population were comparable to those identified in the general cancer population, with immune related adverse events being associated with a minority of both total and potentially preventable admissions.